Fallbericht
Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report
Renal Disease and Transplantation Forum · 13.02.2026 · 19 (1)
DOI: 10.5603/rdatf.112707 ↗Kurz gefasst
Fallbericht in der Zeitschrift Renal Disease and Transplantation Forum, online erschienen am 13.02.2026. Verfasst von Zofia Kania-Bonicka und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kania-Bonicka, Z., Bączkowska, T., & Mucha, K. (2026). Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report. Renal Disease and Transplantation Forum, 19(1). https://doi.org/10.5603/rdatf.112707
Vancouver
Kania-Bonicka Z, Bączkowska T, Mucha K. Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report. Renal Disease and Transplantation Forum. 2026;19(1). doi:10.5603/rdatf.112707
BibTeX
@article{KaniaBonicka2026,
author = {Kania-Bonicka, Zofia and Bączkowska, Teresa and Mucha, Krzysztof},
title = {Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report},
journal = {Renal Disease and Transplantation Forum},
year = {2026},
volume = {19},
number = {1},
doi = {10.5603/rdatf.112707}
}
EUVIMED